Egenera, Inc. v. Cisco Sys., Inc., No. 19-2015 (Fed. Cir. Aug. 28, 2020)

(Judicial Estoppel)

BASF Corp. v. Johnson Matthey Inc., 875 F.3d 1360 (Fed. Cir. 2017)

(Functional Claim Language)

Facebook, Inc. v. Windy City Innovations, LLC, No. 18-1400

(Joinder to Inter Partes Review)

Uniloc 2017 LLC v. Hulu, LLC., No. 19-1686

(Inter Partes Review)

Network-1 Technologies, Inc v. Hewlett-Packard Co., No. 18-2338

(Inter Partes Review; Estoppel)

Packet Intelligence LLC v. NetScout Systems, Inc., No. 19-2041

(Patent Marking)

Spigen Korea Co., Ltd. v. Ultraproof Inc. et al.

(Design Patent; Obviousness)

Lanard Toys Limited v. Dolgencorp LLC et. al.

(Design Patent; Infringement)

SIPCO, LLC v. Emerson Electric Co.

(Covered Business Method Patent Review)

American Axle & Mfg. v. Neapco Holdings

(Subject Matter Eligibility)

Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.

(Written Description)

MTD Products Inc. v. Andrei Iancu

(Means-Plus-Function)

Arthrex, Inc. V. Smith & Nephew, Inc.

(Administrative Procedure Act)

Papst Licensing GMBH & Co. KG v. Samsung Electronics

(Issue Preclusion)

Nuvo Pharmaceuticals v. Dr. Reddy’s Laboratories / Mylan Pharmaceuticals / Lupin Pharmaceuticals

(Written Description)

Ajinomoto Co., v. ITC; CJ Cheiljedang Corp., v. ITC

(Prosecution History Estoppel)

Amgen Inc., v. Coherus Biosciences, Inc.

(Prosecution History Estoppel)

Nestlé USA, Inc. v. Steuben Foods, Inc.

(Collateral Estoppel)

In Re Brandt

(Obviousness)

DSS Technology Management, Inc. v. Apple Inc.

(Obviousness)

SimpleAir, Inc. v. Google LLC

(Terminal Disclaimers)

Bayer Pharma AG v. Watson Laboratories, Inc.

(Obviousness)

Merck Sharp & Dohme Corp. v. Hospira, Inc.

(Obviousness)

Amgen, Inc. v. Sanofi, Aventisub LLC

(Written Description)

Intellectual Ventures I LLC v. Motorola Mobility LLC

(Divided Infringement)

Aqua Products, Inc. v. Matal

(IPR Amendments)

Regeneron Pharmaceuticals, Inc. v. Merus N.V.

(Inequitable Conduct)

AIA America Inc. v. Avid Pharmaceuticals

(Attorneys’ Fees)

Mentor Graphics Corp., v. EVE-USA, Inc.

(Lost Profits)

Romag Fasteners, Inc. v. Fossil, Inc.

(Attorneys’ Fees)

Cleveland Clinic v. True Health Diagnostics LLC

(Patent-Eligibility)

NantKwest, Inc. v. Matal

(Fee Shifting)

Genband LLC v. Metaswitch Networks Corp.

(Permanent Injunctions)

AdjustaCam, LLC v. Newegg, Inc.

(Fee Shifting)

Helsinn Healthcare S.A. v. Teva Pharmaceutical Industries, LTD.

(On-Sale Bar)

Nichia Corp. v. Everlight Americas, Inc.

(Permanent Injunctions)

Intellectual Ventures I LLC v. Erie Indemnity Co.

(Patent Assignments)

Nidec Motor Corp. v. Zhongshan Broad Ocean Motor Co.

(Anticipation)

Icon Health and Fitness, Inc. v. Strava, Inc.

(Obviousness)

MPHJ Technology Investments, LLC v. Ricoh Americas Corporation

(Claim Construction)

Shire Development LLC v. Watson Pharmaceuticals, Inc.

(Transitional Phrases)

Cumberland Pharmaceuticals v. Mylan Institutional LLC (Derivation)

In Re Van Os

(Obviousness)

Phigenix v. ImmunoGen  (Standing)

Sonix Technology v. Publications International (Definiteness)

January Federal Circuit Review

November Federal Circuit Review

October Federal Circuit Review

September Federal Circuit Review

August Federal Circuit Review

July Federal Circuit Review

June Federal Circuit Review

May Federal Circuit Review

April Federal Circuit Review

March Federal Circuit Review

February Federal Circuit Review

January Federal Circuit Review

December Federal Circuit Review

November Federal Circuit Review

September Federal Circuit Review

August Federal Circuit Review

July Federal Circuit Review

June Federal Circuit Review

May Federal Circuit Review

April Federal Circuit Review

March Federal Circuit Review

February Federal Circuit Review

November Federal Circuit Review